$43.68
+0.48 (+1.11%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3.8% upside
Low Target
$37.53
Average Target
$45.36
High Target
$61.85
Current Price
$43.68
Current
$43.68
$43.68
Target
$45.36
$45.36
$37.53
$45.36 avg
$61.85
Scenario Analysis
Bear Case
$37.53
-14.1%
Low target
Base Case
$45.36
+3.8%
Avg target
Bull Case
$61.85
+41.6%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$50.81
-14.0% from high
52-Week Low
$15.86
+175.4% from low
Target vs 52W High
$45.36
-10.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |